Acta Medica International

REVIEW ARTICLE
Year
: 2015  |  Volume : 2  |  Issue : 2  |  Page : 118--129

WHO recommended tools to improve diagnosis of active and drug resistant tuberculosis


Shubhada Shenai 
 Center for Emerging Pathogens, Department of Medicine, New Jersey Medical School - Rutgers University, Newark, New Jersey, USA

Correspondence Address:
Shubhada Shenai
Research Scientist/Research Teaching Specialist (RTS). Department of Medicine, Division of Infectious Diseases, Center for Emerging and Re-emerging Pathogens, Rutgers New Jersey Medical School, Rutgers Biomedical and Health Sciences, 185 South Orange Avenue, MSB A920G, Newark, NJ 07103
USA

The successful arrest or cure of tuberculosis (TB) depends largely on early case detection and proper treatment. Currently, several promising diagnostic tools with improved sensitivity and speed are available. Old microscopic and culture based technologies have been revisited and new molecular technologies have been developed. In recent years, World Health Organization (WHO) evaluated and endorsed different TB diagnostic tools and published various policy statements. These policy statements address improvements in smear microscopy, use of commercial and non-commercial culture based techniques and rapid molecular assays. This is the first comprehensive review compiling pros and cons of WHO recommended TB diagnostic tools for effective implementation in TB endemic regions.


How to cite this article:
Shenai S. WHO recommended tools to improve diagnosis of active and drug resistant tuberculosis.Acta Med Int 2015;2:118-129


How to cite this URL:
Shenai S. WHO recommended tools to improve diagnosis of active and drug resistant tuberculosis. Acta Med Int [serial online] 2015 [cited 2021 Jun 24 ];2:118-129
Available from: https://www.actamedicainternational.com/article.asp?issn=2349-0578;year=2015;volume=2;issue=2;spage=118;epage=129;aulast=Shenai;type=0